[Federal Register Volume 76, Number 34 (Friday, February 18, 2011)]
[Notices]
[Page 9578]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2011-3708]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP): National Spina Bifida Patient Registry--Clinic 
Demonstration Project (U01), Funding Opportunity Announcement (FOA) 
DD11-001, Initial Review

    In accordance with Section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the aforementioned meeting:

    Time and Date: 1 p.m.-4 p.m., March 31, 2011 (Closed).
    Place: Teleconference.
    Status: The meeting will be closed to the public in accordance 
with provisions set forth in Section 552b(c)(4) and (6), Title 5 
U.S.C., and the Determination of the Director, Management Analysis 
and Services Office, CDC, pursuant to Public Law 92-463.
    Matters to be Discussed: The meeting will include the initial 
review, discussion, and evaluation of the ``National Spina Bifida 
Patient Registry--Clinic Demonstration Project (U01), FOA DD11-001, 
initial review.''
    Contact Person for More Information: Hylan D. Shoob, PhD, 
M.S.P.H., Scientific Review Officer, Office of the Associate 
Director for Science, Office of the Director, CDC, 1600 Clifton 
Road, NE., Mailstop D-72, Atlanta, GA 30333, Telephone: (404) 639-
4796, E-mail: [email protected].
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention 
and the Agency for Toxic Substances and Disease Registry.

    Dated: February 14, 2011.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.

[FR Doc. 2011-3708 Filed 2-17-11; 8:45 am]
BILLING CODE 4163-18-P